Peter P. Pfreundschuh
2018 - UroGen Pharma Ltd.
In 2018, Peter P. Pfreundschuh earned a total compensation of $2.5M as Chief Financial Officer at UroGen Pharma Ltd..
Compensation breakdown
| Non-Equity Incentive Plan | $96,800 |
|---|---|
| Option Awards | $1,704,505 |
| Salary | $156,424 |
| Stock Awards | $527,875 |
| Other | $197 |
| Total | $2,485,800 |
Pfreundschuh received $1.7M in option awards, accounting for 69% of the total pay in 2018.
Pfreundschuh also received $96.8K in non-equity incentive plan, $156.4K in salary, $527.9K in stock awards and $197 in other compensation.
Rankings
In 2018, Peter P. Pfreundschuh's compensation ranked 4,698th out of 14,244 executives tracked by ExecPay. In other words, Pfreundschuh earned more than 67.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,698 out of 14,244 | 67th |
Division Manufacturing | 1,766 out of 5,759 | 69th |
Major group Chemicals And Allied Products | 639 out of 2,122 | 70th |
Industry group Drugs | 537 out of 1,811 | 70th |
Industry Pharmaceutical Preparations | 414 out of 1,385 | 70th |
Source: SEC filing on April 29, 2020.
Pfreundschuh's colleagues
We found six more compensation records of executives who worked with Peter P. Pfreundschuh at UroGen Pharma Ltd. in 2018.
2018
Ron Bentsur
UroGen Pharma Ltd.
Chief Executive Officer
2018
Stephen Mullennix
UroGen Pharma Ltd.
Chief Financial Officer
2018
Gil Hakim
UroGen Pharma Ltd.
Former President
2018
Gary Titus
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Mark Schoenberg
UroGen Pharma Ltd.
Chief Medical Officer
News
Korro Bio CEO David Lucchino's 2020 pay falls 29% to $5.2M
April 29, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett's 2020 pay falls 90% to $2.5M
April 28, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett receives $26M in 2019
April 29, 2020
UroGen Pharma Ltd. CEO Ron Bentsur's 2018 pay jumps 202% to $6M
April 26, 2019